|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:CEO
|
gptkb:Gábor_Orbán
|
|
gptkbp:country
|
gptkb:Hungary
|
|
gptkbp:foundedBy
|
gptkb:Gedeon_Richter
|
|
gptkbp:foundedYear
|
1901
|
|
gptkbp:headquartersLocation
|
gptkb:Budapest
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Richter Gedeon Plc
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:ISIN
|
HU0000123096
|
|
gptkbp:listedOn
|
gptkb:Budapest_Stock_Exchange
|
|
gptkbp:market
|
gptkb:Asia
gptkb:Europe
gptkb:United_States
gptkb:CIS_countries
|
|
gptkbp:notableProduct
|
gptkb:Cariprazine
gptkb:Cavinton
gptkb:Escapelle
|
|
gptkbp:numberOfEmployees
|
over 12,000
|
|
gptkbp:products
|
pharmaceuticals
biosimilars
generic drugs
women's healthcare products
|
|
gptkbp:researchInterest
|
biosimilars
women's health
central nervous system disorders
|
|
gptkbp:revenue
|
over 2 billion EUR (2022)
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:stockExchange
|
gptkb:Budapest_Stock_Exchange
|
|
gptkbp:subsidiary
|
gptkb:Grindeks
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
https://www.richter.hu/
|
|
gptkbp:bfsParent
|
gptkb:IUPAC-Richter_Prize_in_Medicinal_Chemistry
|
|
gptkbp:bfsLayer
|
6
|